CVS Caremark Applauds FTC's Leadership on Follow-on Biologics
November 21 2008 - 10:30AM
PR Newswire (US)
Calls on Congress to Move Swiftly to Provide Patients and Payors
Access and Savings WOONSOCKET, R.I., Nov. 21 /PRNewswire/ -- CVS
Caremark today applauded the Federal Trade Commission (FTC) for
holding a public Roundtable to address issues of competition and
continued innovation under a framework for follow-on biologic
drugs. "CVS Caremark serves millions of patients, many of whom
depend on specialty drugs to provide life-saving and life-enhancing
treatments for their serious conditions. We support the creation of
a federal legislative pathway for FDA approval of these medicines
to provide access and savings to patients and payors," said Dave
Golding, R.Ph., Executive Vice President for Specialty Pharmacy
services at CVS Caremark. "Increased competition in the biologics
market will benefit health plans, employers and federal programs,
and more importantly, will help make specialty medicines more
affordable for patients, many of whom must take these medicines for
their entire lives." Golding was a participant at the FTC
Roundtable. CVS Caremark Specialty Pharmacy is a full-service
pharmacy that specializes in serving the pharmacy needs of people
who require complex and chronic therapies for conditions such as
hemophilia, multiple sclerosis, HIV/AIDS, Cancer and Organ
Transplant. Patients who use CVS Caremark Specialty Pharmacy
services receive: -- Easy referral process with prompt intake and
same day turnaround -- Dedicated interdisciplinary CareTeam --
Pharmacist-led care coordination -- 24/7 clinical support and
counseling -- Dedicated disease program toll-free telephone and fax
line -- Patient education material -- Discrete, timely delivery of
medication anywhere in the US About CVS Caremark CVS Caremark is
the largest provider of prescriptions in the nation. The Company
fills or manages more than 1 billion prescriptions annually.
Through its unmatched breadth of service offerings, CVS Caremark is
transforming the delivery of health care services in the U.S. The
Company is uniquely positioned to effectively manage costs and
improve health care outcomes through its more than 6,800
CVS/pharmacy and Longs Drugs stores; its Caremark Pharmacy Services
division (pharmacy benefit management, mail order and specialty
pharmacy); its retail-based health clinic subsidiary, MinuteClinic;
and its online pharmacy, CVS.com. General information about CVS
Caremark is available through the Investor Relations section of the
Company's Web site, at cvscaremark.com/investors, as well as
through the press room section of the Company's Web site, at
cvscaremark.com/newsroom. Media Contact: Christine K. Cramer CVS
Caremark 401-770-3317 DATASOURCE: CVS Caremark CONTACT: Christine
K. Cramer of CVS Caremark, +1-401-770-3317, Web site:
http://www.cvs.com/ http://www.cvscaremark.com/newsroom
http://www.cvscaremark.com/investors
Copyright